Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

FEATURES OF PATIENTS ADMITTED WITH HEART FAILURE AND HAVING DIURETIC RESISTANCE

View through CrossRef
Objective: The current study aimed to identify the features of diuretic resistance (DR) in patients with heart failurewho were hospitalized in a tertiary care hospital’s cardiology department.Materials & Methods: Between January 1, 2014, and December 31, 2014, retrospective observational researchwas carried out in the Khyber Teaching Hospital cardiology department in Peshawar. There were 560 adult patientsdiagnosed with heart failure who were hospitalized within a year. Excluded patients were 152 who were released inless than 24 hours and 113 whose full data was not accessible. Thus, the research comprised the remaining patients(560-152-113= 295) whose records were examined. A cutoff point of 160 mg of furosemide per day was establishedfor patients I/V, who were classified as diuretic responders (using < 160 mg/day; group I) and diuretic resistant(using > 160 mg/day; group II).Results: There were 295 patients, of whom 175 (59.32%) were male and 120 (40.67%) were female. The patients’average age was 65+7 years. Group I consisted of 190 patients (64.4%) who responded to diuretics, whereas groupII consisted of 105 patients (35.9%) who were resistant to diuretics. In group I, there were 114 (60%) males and 76(40%) females; in group II, there were 61 (58%) males and 44 (41%) females. Clinical and laboratory parameters,comorbidities, and the kind of therapy each group got were compared. Compared to group I, patients with DR (groupII) had noticeably greater rates of CAD, diabetes, and asthma. DR patients (Group II) had lower heart rates andblood pressure systolic and diastolic than those in Group I. However, group I had a higher JVP and more noticeableedema in the foot. Compared to group I, patients with DR (group II) had higher rates of anemia, hypokalemic, andhyponatremic conditions. In addition, their creatinine, glucose, and cholesterol levels were higher than those of group I.Those with DR (Group II) used B Blockers, spironolactone, and inotropes at much greater rates than those in Group I.Conclusion: Patients with heart failure often struggle with diuretic resistance. Patients with DR have substantiallydistinct characteristics from those who react well to diuretics. When such patients are identified early on, doctors canadopt more aggressive treatment plans, which promotes quicker healing and shorter hospital stays.Keywords: Diuretic Resistance, heart failure
Title: FEATURES OF PATIENTS ADMITTED WITH HEART FAILURE AND HAVING DIURETIC RESISTANCE
Description:
Objective: The current study aimed to identify the features of diuretic resistance (DR) in patients with heart failurewho were hospitalized in a tertiary care hospital’s cardiology department.
Materials & Methods: Between January 1, 2014, and December 31, 2014, retrospective observational researchwas carried out in the Khyber Teaching Hospital cardiology department in Peshawar.
There were 560 adult patientsdiagnosed with heart failure who were hospitalized within a year.
Excluded patients were 152 who were released inless than 24 hours and 113 whose full data was not accessible.
Thus, the research comprised the remaining patients(560-152-113= 295) whose records were examined.
A cutoff point of 160 mg of furosemide per day was establishedfor patients I/V, who were classified as diuretic responders (using < 160 mg/day; group I) and diuretic resistant(using > 160 mg/day; group II).
Results: There were 295 patients, of whom 175 (59.
32%) were male and 120 (40.
67%) were female.
The patients’average age was 65+7 years.
Group I consisted of 190 patients (64.
4%) who responded to diuretics, whereas groupII consisted of 105 patients (35.
9%) who were resistant to diuretics.
In group I, there were 114 (60%) males and 76(40%) females; in group II, there were 61 (58%) males and 44 (41%) females.
Clinical and laboratory parameters,comorbidities, and the kind of therapy each group got were compared.
Compared to group I, patients with DR (groupII) had noticeably greater rates of CAD, diabetes, and asthma.
DR patients (Group II) had lower heart rates andblood pressure systolic and diastolic than those in Group I.
However, group I had a higher JVP and more noticeableedema in the foot.
Compared to group I, patients with DR (group II) had higher rates of anemia, hypokalemic, andhyponatremic conditions.
In addition, their creatinine, glucose, and cholesterol levels were higher than those of group I.
Those with DR (Group II) used B Blockers, spironolactone, and inotropes at much greater rates than those in Group I.
Conclusion: Patients with heart failure often struggle with diuretic resistance.
Patients with DR have substantiallydistinct characteristics from those who react well to diuretics.
When such patients are identified early on, doctors canadopt more aggressive treatment plans, which promotes quicker healing and shorter hospital stays.
Keywords: Diuretic Resistance, heart failure.

Related Results

Frequency of Common Chromosomal Abnormalities in Patients with Idiopathic Acquired Aplastic Anemia
Frequency of Common Chromosomal Abnormalities in Patients with Idiopathic Acquired Aplastic Anemia
Objective: To determine the frequency of common chromosomal aberrations in local population idiopathic determine the frequency of common chromosomal aberrations in local population...
Evolution of Antimicrobial Resistance in Community vs. Hospital-Acquired Infections
Evolution of Antimicrobial Resistance in Community vs. Hospital-Acquired Infections
Abstract Introduction Hospitals are high-risk environments for infections. Despite the global recognition of these pathogens, few studies compare microorganisms from community-acqu...
Emerging Evidence of IgG4-Related Disease in Pericarditis: A Systematic Review
Emerging Evidence of IgG4-Related Disease in Pericarditis: A Systematic Review
Abstract Introduction Immunoglobulin G4-related disease (IgG4-RD) is a recently identified immune-mediated condition that is debilitating and often overlooked. While IgG4-RD has be...
Etiology and predictors of heart failure in pregnancy. Newer Insights from the M-PAC registry
Etiology and predictors of heart failure in pregnancy. Newer Insights from the M-PAC registry
Abstract Background Women with heart disease undergoing pregnancy is on the increase, along with an increasing cardiac contribut...
Decongestion (instead of ultrafiltration?)
Decongestion (instead of ultrafiltration?)
Purpose of review To summarize the contemporary evidence on decongestion strategies in patients with acute heart failure (AHF). Recent...
Empagliflozin in the Real World: Strengthening Heart Failure Care in Pakistan
Empagliflozin in the Real World: Strengthening Heart Failure Care in Pakistan
Heart failure with reduced ejection fraction (HFrEF) remains a major clinical challenge worldwide and is a pressing public health issue in Pakistan. Patients here often present at ...

Back to Top